Literature DB >> 24569437

Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial.

Stephanie R Land1, Qing Liu, D Lawrence Wickerham, Joseph P Costantino, Patricia A Ganz.   

Abstract

BACKGROUND: NSABP P-1 provides an opportunity to examine the association of behavioral factors with prospectively monitored cancer incidence and interactions with tamoxifen.
METHODS: From 1992 to 1997, 13,388 women with estimated 5-year breast cancer risk greater than 1.66% or a history of lobular carcinoma in situ (87% younger than age 65; 67% postmenopausal) were randomly assigned to tamoxifen versus placebo. Invasive breast cancer, lung cancer, colon cancer, and endometrial cancer were analyzed with Cox regression. Predictors were baseline cigarette smoking, leisure-time physical activity, alcohol consumption, and established risk factors.
RESULTS: At median 7 years follow-up, we observed 395, 66, 35, and 74 breast cancer, lung cancer, colon cancer, and endometrial cancer, respectively. Women who had smoked were at increased risk of breast cancer (P = 0.007; HR = 1.3 for 15-35 years smoking, HR = 1.6 for ≥ 35 years), lung cancer (P < 0.001; HR = 3.9 for 15-35 years, HR = 18.4 for ≥ 35 years), and colon cancer (P < 0.001; HR = 5.1 for ≥ 35 years) versus never-smokers. Low activity predicted increased breast cancer risk only among women assigned to placebo (P = 0.021 activity main effect, P = 0.013 activity-treatment interaction; HR = 1.4 for the placebo group) and endometrial cancer among all women (P = 0.026, HR = 1.7). Moderate alcohol (>0-1 drink/day) was associated with decreased risk of colon cancer (P = 0.019; HR = 0.35) versus no alcohol. There were no other significant associations between these behaviors and cancer risk.
CONCLUSION: Among women with elevated risk of breast cancer, smoking has an even greater impact on breast cancer risk than observed in past studies in the general population. IMPACT: Women who smoke or are inactive should be informed of the increased risk of multiple types of cancer. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24569437      PMCID: PMC4011972          DOI: 10.1158/1055-9965.EPI-13-1105-T

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  51 in total

1.  Host factors, behaviors, and clinical trials: opportunities and challenges.

Authors:  Patricia A Ganz
Journal:  J Clin Oncol       Date:  2012-07-02       Impact factor: 44.544

2.  Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Stephanie R Land; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-07

3.  Methodologic barriers to addressing critical questions about tobacco and cancer prognosis.

Authors:  Stephanie R Land
Journal:  J Clin Oncol       Date:  2012-05-07       Impact factor: 44.544

4.  Tobacco cessation and control a decade later: American society of clinical oncology policy statement update.

Authors:  Nasser Hanna; James Mulshine; Dana S Wollins; Courtney Tyne; Carolyn Dresler
Journal:  J Clin Oncol       Date:  2013-07-29       Impact factor: 44.544

5.  Breast cancer risk among women who start smoking as teenagers.

Authors:  Inger T Gram; Tonje Braaten; Paul D Terry; Annie J Sasco; Hans-Olov Adami; Eiliv Lund; Elisabete Weiderpass
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

6.  Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials.

Authors:  Erica N Peters; Essie Torres; Benjamin A Toll; K Michael Cummings; Ellen R Gritz; Andrew Hyland; Roy S Herbst; James R Marshall; Graham W Warren
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

Review 7.  Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012.

Authors:  Helmut K Seitz; Claudio Pelucchi; Vincenzo Bagnardi; Carlo La Vecchia
Journal:  Alcohol Alcohol       Date:  2012-03-29       Impact factor: 2.826

8.  Active smoking and breast cancer risk: original cohort data and meta-analysis.

Authors:  Mia M Gaudet; Susan M Gapstur; Juzhong Sun; W Ryan Diver; Lindsay M Hannan; Michael J Thun
Journal:  J Natl Cancer Inst       Date:  2013-02-28       Impact factor: 13.506

9.  Accuracy of self-reported tobacco use in newly diagnosed cancer patients.

Authors:  Nelson A Morales; Michelle A Romano; K Michael Cummings; James R Marshall; Andrew J Hyland; Alan Hutson; Graham W Warren
Journal:  Cancer Causes Control       Date:  2013-04-04       Impact factor: 2.506

10.  Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement.

Authors:  Benjamin A Toll; Thomas H Brandon; Ellen R Gritz; Graham W Warren; Roy S Herbst
Journal:  Clin Cancer Res       Date:  2013-04-09       Impact factor: 12.531

View more
  14 in total

Review 1.  Does smoking influence the physical activity and lung cancer relation? A systematic review and meta-analysis.

Authors:  Daniela Schmid; Cristian Ricci; Gundula Behrens; Michael F Leitzmann
Journal:  Eur J Epidemiol       Date:  2016-08-08       Impact factor: 8.082

Review 2.  Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.

Authors:  Lori M Minasian; Catherine M Tangen; D Lawrence Wickerham
Journal:  Semin Oncol       Date:  2015-07-10       Impact factor: 4.929

3.  Functional analysis of CD14+HLA-DR-/low myeloid-derived suppressor cells in patients with lung squamous cell carcinoma.

Authors:  Yun Chen; Guichang Pan; Dongbo Tian; Yifei Zhang; Taoping Li
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

Review 4.  A systematic review and meta-analysis of physical activity and endometrial cancer risk.

Authors:  Daniela Schmid; Gundula Behrens; Marlen Keimling; Carmen Jochem; Cristian Ricci; Michael Leitzmann
Journal:  Eur J Epidemiol       Date:  2015-03-24       Impact factor: 8.082

5.  Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.

Authors:  Stephanie R Land; Farzana L Walcott; Qing Liu; D Lawrence Wickerham; Joseph P Costantino; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2015-11-27       Impact factor: 13.506

6.  Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases.

Authors:  Michael N Passarelli; Polly A Newcomb; John M Hampton; Amy Trentham-Dietz; Linda J Titus; Kathleen M Egan; John A Baron; Walter C Willett
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

7.  Occurrence of Occult Malignancies in Reduction Mammoplasties.

Authors:  Matthias Waldner; Holger J Klein; Walter Künzi; Merlin Guggenheim; Jan A Plock; Pietro Giovanoli
Journal:  Front Surg       Date:  2018-02-28

8.  Association Between Physical Activity and Lower Risk of Lung Cancer: A Meta-Analysis of Cohort Studies.

Authors:  Yang Liu; Yue Li; Yun-Peng Bai; Xiao-Xi Fan
Journal:  Front Oncol       Date:  2019-01-22       Impact factor: 6.244

9.  Lifestyle changes for prevention of breast cancer.

Authors:  Seyed Hesam Bani Hashemi; Samieh Karimi; Hamidreza Mahboobi
Journal:  Electron Physician       Date:  2014-07-01

10.  Identification of microRNAs as potential markers of ovarian toxicity.

Authors:  Hayley C Furlong; Martin R Stämpfli; Anne M Gannon; Warren G Foster
Journal:  J Appl Toxicol       Date:  2018-01-29       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.